We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

1 hedge funds and large institutions have $34.3M invested in Ariad Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 191 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding in top 10

Funds holding in top 10: 9 → 1 (-8)

98% less capital invested

Capital invested by funds: $2.13B → $34.3M (-$2.09B)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 191

100% less funds holding

Funds holding: 200 → 1 (-199)

Holders
1
Holders Change
-199
Holders Change %
-99.5%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-88.89%
% of All Funds
0.02%
New
1
Increased
–
Reduced
–
Closed
191
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$16.5M

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$32M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$225M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$218M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$182M
4
SCM
Sarissa Capital Management
Connecticut
-$160M
5
State Street
State Street
Massachusetts
-$97.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
QIM
51
Quantitative Investment Management
Virginia
– -$4.46M -358,800 Closed
TA
52
Teachers Advisors
New York
– -$4.34M -348,713 Closed
California Public Employees Retirement System
53
California Public Employees Retirement System
California
– -$4.11M -330,200 Closed
Swiss National Bank
54
Swiss National Bank
Switzerland
– -$3.55M -285,100 Closed
CEP
55
Chicago Equity Partners
Illinois
– -$3.19M -256,540 Closed
GC
56
Guggenheim Capital
Illinois
– -$3.16M -253,807 Closed
Millennium Management
57
Millennium Management
New York
– -$3.12M -250,925 Closed
RSCM
58
Rock Springs Capital Management
Maryland
– -$3.11M -250,000 Closed
DCM
59
Dynamic Capital Management
Jersey
– -$3.1M -249,231 Closed
FAM
60
Fred Alger Management
New York
– -$2.96M -237,733 Closed
JP Morgan Chase
61
JP Morgan Chase
New York
– -$2.86M -229,736 Closed
Invesco
62
Invesco
Georgia
– -$2.83M -227,331 Closed
CS
63
Credit Suisse
Switzerland
– -$2.69M -216,373 Closed
USAA
64
United Services Automobile Association
Texas
– -$2.68M -215,350 Closed
GAM
65
Gotham Asset Management
New York
– -$2.62M -210,936 Closed
CS
66
Candriam SCA
Luxembourg
– -$2.61M -210,000 Closed
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
– -$2.57M -206,352 Closed
TRSOTSOK
68
Teachers Retirement System of the State of Kentucky
Kentucky
– -$2.5M -201,070 Closed
ARTA
69
A.R.T. Advisors
New York
– -$2.46M -198,100 Closed
AQR Capital Management
70
AQR Capital Management
Connecticut
– -$2.38M -191,513 Closed
IIM
71
Ironwood Investment Management
Massachusetts
– -$2.38M -191,170 Closed
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
– -$2.25M -181,200 Closed
Citadel Advisors
73
Citadel Advisors
Florida
– -$2.25M -180,772 Closed
Wells Fargo
74
Wells Fargo
California
– -$2.22M -178,632 Closed
NFA
75
Nationwide Fund Advisors
Ohio
– -$2.1M -168,431 Closed
1 2
3
4 5

ARIA Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2017, worth a combined $34.3M — down 98% from $2.13B a quarter earlier.

Sellers outnumbered buyers: 191 funds closed out of ARIA and 1 opened new positions — a net loss of 190 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $225M sold.

  • 1 institutional investor held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2017, down from 200 in Q4 2016.
  • Funds reported $34.3M of Ariad Pharmaceuticals Inc stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Ariad Pharmaceuticals Inc positions in Q1 2017 and 191 closed out, a net change of -190 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2017 was FNY Partners Fund, an estimated $32M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2017 was Fidelity Investments, an estimated $225M sold.

Based on aggregated 13F filings for Q1 2017.